China Pharma Inc. (CPHI)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
0.20
-0.00 (-0.60%)
At close: Jan 14, 2025, 3:59 PM
0.21
2.41%
Pre-market Jan 15, 2025, 06:43 AM EST
undefined% (undefined)
Bid | 0.2 |
Market Cap | 3.86M |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | -0.25 |
PE Ratio (ttm) | -0.8 |
Forward PE | n/a |
Analyst | n/a |
Ask | 0.21 |
Volume | 196,050 |
Avg. Volume (20D) | 838,195 |
Open | 0.21 |
Previous Close | 0.20 |
Day's Range | 0.20 - 0.21 |
52-Week Range | 0.13 - 0.60 |
Beta | undefined |
About CPHI
China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products primarily to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. Its products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit;...